Phase III anti-HIV microbicide trial in Africa and India stopped as preliminary results show gel may increase risk of infection

A Phase III trial of a candidate microbicide gel to prevent HIV infection in women has been halted because more participants using the gel were becoming infected than those in the placebo group. A trial of the same gel in Nigeria has also been stopped as a precaution.